NR2E3 and hepatocellular carcinoma: Consistently, high NR2E3 expression significantly correlated with favorable clinical outcomes for relapse‐free survival and progress‐free survival among HCC patients in advanced stages III and IV (Figure 1D; Figure S3, Supporting Information).